Evidence map›Paper›PMID 41881384›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2026

Implications of Acute Kidney Injury Requiring Dialysis Versus End-Stage Kidney Disease Status.

Ian E McCoy, Eugene Lin

Abstract readReviewComparative Study
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ian E McCoyDivision of Nephrology, University of California, San Francisco, San Francisco, California. Electronic address: ian.mccoy@ucsf.edu.
Eugene LinDivision of Nephrology, Departments of Medicine and Health Policy & Management, Keck School of Medicine of USC and USC Sol Price School of Public Policy, California; Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, California.

Funding

Elucidating the Mechanisms of Racial and Ethnic Disparities in Dialysis QualityR01DK137223 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Eugene Lin · 2023 to 2026
$2.0M
Towards improving recovery from dialysis-requiring acute kidney injuryK23DK128605 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Ian McCoy · 2022 to 2026
$1.0M
NIDDK NIH HHS K23 DK128605NIDDK NIH HHS R01 DK137223
6 · The paper itself

Abstract

More than 20% of patients receiving dialysis at in-center hemodialysis facilities initiate dialysis for acute kidney injury requiring dialysis (AKI-D) rather than end-stage kidney disease (ESKD). The transition from AKI-D to ESKD status is important to reorient clinical efforts from short-term monitoring for recovery to equally important long-term goals of establishing permanent dialysis access and planning for kidney transplant. The timing of this transition is highly variable and determined by the treating nephrologist. Because of numerous subtle policy differences, the implications of transitioning a patient receiving dialysis for AKI-D to ESKD status can be complex and far-reaching. Here, we aim to describe the financial and nonfinancial implications of the AKI-D-to-ESKD status transition. Clinicians and policymakers alike may be able to improve the care of this vulnerable patient population through a better understanding of these implications. We conclude with policy recommendations to address disincentives to optimal care.

Indexed as

Acute Kidney InjuryKidney Failure, ChronicRenal DialysisHumansAcute kidney injurydialysiseconomicsESKDESRDkidney replacement therapy

Identifiers

PMID41881384
PMCPMC13317814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.